Sylvester Comprehensive Cancer Center

E-mail a Friend

Ronald B. Goldberg, M.D.

General Information

Ronald B. Goldberg, M.D.

Languages

  • English

Specialties

  • Endocrinology, Diabetes and Metabolism

Roles

  • Associate Director, Diabetes Research Institute
  • Director, Lipid Disorder Clinic
  • Professor of Medicine

Clinical Interests

Lipid disorders, diabetes, metabolic symdrome

Research Interests

Prevention of type 2 diabetes, diabetes, metabolic symdrome, cardiovascular disease

Education

Undergraduate
University of Witwatersrand
Graduate
University of Witwatersrand
Residency
Johannesburg General Hospital
Fellowship
University of Chicago Hospitals and Health System

Biography


Dr. Ronald B Goldberg is Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, serves on the Executive Council of the Diabetes Research Institute (DRI), and has a secondary appointment as Associate Professor, Department of Biochemistry and Molecular Biology.

He completed his medical training in Johannesburg, South Africa, emigrating to the United States in 1977 to complete his Endocrine training at the University of Chicago, where he was a SCOR Atherosclerosis Trainee, before taking up a faculty position at the University of Miami Miller School of Medicine. During his tenure he has served as Chief of the Division of Diabetes and Metabolism (1988-1999) and Director of the DRI Kosow Diagnostic and Treatment Center (1986-1999) and was responsible for setting up the DRI Clinical research Laboratory of which he is still Co-Director. He is also a Diplomate of the American Board of Clinical Lipidology.

His research is directed at the prevention of metabolic syndrome and type 2 diabetes and their complications especially cardiovascular disease, and on biomarkers of cardiometabolic damage, particularly the lipoproteins. He is a Principal Investigator of the NIH funded Diabetes Prevention Program and also of its NIH-funded ancillary biomarker in diabetes study. He is also a Principal Investigator of studies funded either by industry or jointly with the NIH focused on the pharmacotherapy of atherosclerotic disease prevention. In addition he brings his expertise in these areas as an investigator to several collaborative NIH funded studies that include a study of stroke, a study of the effect of the built environment on development of the metabolic syndrome in recently arrived Cuban immigrants and an investigation of atherosclerosis risk in children with HIV on long-term antiretroviral therapy. He has a strong interest in undergraduate and postgraduate medical education, and was the Director of the Southeast Florida Diabetes Center Program, a State funded activity devoted mainly to education from 1996-2008. He is active in mentoring Fellows in the Division of Endocrinology and medical residents in their research projects and directs the University of Miami Lipid Disorders Clinic as well as the Diabetes Clinic at the Jackson Health Center.


 

E-mail a Friend